So long as post-operative nausea and vomiting (PONV) continues to have negative clinical and economic consequences, you can expect that pharmaceutical companies and researchers will continue to develop new agents, therapeutic options and antiemetic regimens. Here's a quick review of what's available to help anesthesia providers tailor antiemetic regimens for every patient.